News
Public · Published
GE HealthCare 3Q 2026: Revenue $5.51B, Net income $615M, EPS $1.36— 10-Q Summary
GE HealthCare reported third-quarter 2026 revenue of $5.51 billion, up 7.2% from a year earlier. Net income rose to $615 million from $446 million, while diluted earnings per share increased to $1.36 from $0.98.
Published:
Updated:
What happened
GE HealthCare reported third-quarter 2026 revenue of $5.51 billion, up 7.2% from a year earlier. Net income rose to $615 million from $446 million, while diluted earnings per share increased to $1.36 from $0.98.
Confirmed
Global impact / market context
Higher revenue and profit per sale mean GE HealthCare keeps more money from each dollar of sales. That extra cash can fund research, pay down borrowed money, or absorb tariff costs, which supports future earnings for investors.
Analyst inference
Growth was led by Pharmaceutical Diagnostics and Advanced Imaging Solutions, while U.S. and Canada revenue rose 13.3%. China, tariffs and competition stayed headwinds, so the company's ability to offset tariff costs shapes how durable this profit growth is.
Analyst inference
What to watch
- Tariffs, geopolitical disruption and competition in China remained headwinds, and the company said mitigation measures may not fully offset tariff costs. Confirmed
- Watch whether GE HealthCare expands its tariff mitigation steps, such as shifting suppliers or raising prices, because those choices affect costs and profit per sale. Proposed
- Patient Care Solutions revenue rose 8.5% as fulfillment improved, but nine-month revenue was down 4%; watch whether that recovery holds in coming quarters. Analyst inference
Evidence
- Original source link unavailable